The Role of the Inhibitory Ligand HVEM and Its Receptors CD160 and BTLA in the Regulation of Anti-retroviral T Cell Responses

  1. David, Paul
  2. Westmeier, Jaana
  3. Drabczyk-Pluta, Malgorzata
  4. Werner, Tanja
  5. Ickler, Julia
  6. Francois, Sandra
  7. Bayer, Wibke
  8. Sutter, Kathrin
  9. Del Rio, Maria Luisa 1
  10. Rodriguez-Barbosa, Jose-Ignacio 1
  11. Dittmer, Ulf
  12. Zelinskyy, Gennadiy
  1. 1 Universidad de León
    info

    Universidad de León

    León, España

    ROR https://ror.org/02tzt0b78

Revista:
Frontiers in Virology

ISSN: 2673-818X

Año de publicación: 2022

Volumen: 2

Tipo: Artículo

DOI: 10.3389/FVIRO.2022.836291 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Frontiers in Virology

Objetivos de desarrollo sostenible

€ Ver financiación

Información de financiación

Financiadores

Referencias bibliográficas

  • Sharpe, (2007), Nat Immunol., 8, pp. 239, 10.1038/ni1443
  • Takamura, (2010), J Immunol., 184, pp. 4696, 10.4049/jimmunol.0903478
  • Zelinskyy, (2011), J Immunol., 187, pp. 3730, 10.4049/jimmunol.1101612
  • Greenough, (2010), Thorax., 65, pp. 998, 10.1136/thx.2010.139915
  • Kasprowicz, (2008), J Virol., 82, pp. 3154, 10.1128/JVI.02474-07
  • Zhang, (2008), Gastroenterology., 134, pp. 1938, 10.1053/j.gastro.2008.03.037
  • Petrovas, (2007), Blood., 110, pp. 928, 10.1182/blood-2007-01-069112
  • Santosuosso, (2011), PLoS One., 6, pp. e18465, 10.1371/journal.pone.0018465
  • Akhmetzyanova, (2015), PLoS Pathog., 11, pp. e1005224, 10.1371/journal.ppat.1005224
  • David, (2019), Front Immunol., 10, pp. 54, 10.3389/fimmu.2019.00054
  • Rocamonde, (2019), Retrovirology., 16, pp. 45, 10.1186/s12977-019-0506-x
  • Wong, (2019), Front Immunol., 10, pp. 1435, 10.3389/fimmu.2019.02517
  • Patel, (2015), Mol Cancer Ther., 14, pp. 847, 10.1158/1535-7163.MCT-14-0983
  • Schonrich, (2019), Front Cell Infect Microbiol., 9, pp. 207, 10.3389/fcimb.2019.00207
  • Rodriguez-Barbosa, (2019), Cell Mol Immunol., 16, pp. 679, 10.1038/s41423-019-0241-1
  • Wang, (2005), J Clin Invest., 115, pp. 711, 10.1172/JCI200522982
  • Sedy, (2019), Adv Cancer Res., 142, pp. 145, 10.1016/bs.acr.2019.01.004
  • Demerle, (2021), Front Oncol., 11, pp. 682007, 10.3389/fonc.2021.682007
  • Peretz, (2012), PLoS Pathog., 8, pp. e1002840, 10.1371/journal.ppat.1002840
  • Grabmeier-Pfistershammer, (2017), Clin Immunol., 183, pp. 167, 10.1016/j.clim.2017.09.002
  • Del Rio, (2021), Transl Res., 239, pp. 103, 10.1016/j.trsl.2021.08.006
  • del Rio, (2016), MAbs., 8, pp. 478, 10.1080/19420862.2015.1132130
  • Lilly, (1973), Virology., 55, pp. 363, 10.1016/0042-6822(73)90176-1
  • Robertson, (2008), J Virol., 82, pp. 408, 10.1128/JVI.01413-07
  • Windmann, (2019), mBio., 10, pp. e00004, 10.1128/mBio.00004-19
  • D'Souza, (2007), J Immunol., 179, pp. 1979, 10.4049/jimmunol.179.3.1979
  • del Rio, (2012), J Immunol., 188, pp. 4885, 10.4049/jimmunol.1103698
  • Del Rio, (2017), Transl Res., 181, pp. 83, 10.1016/j.trsl.2016.09.004
  • Zelinskyy, (2009), Blood., 114, pp. 3199, 10.1182/blood-2009-03-208736
  • Chen, (1996), J Virol., 70, pp. 7773, 10.1128/jvi.70.11.7773-7782.1996
  • Schepers, (2002), J Immunol., 169, pp. 3191, 10.4049/jimmunol.169.6.3191
  • Rose, (2012), Cytometry A., 81, pp. 343, 10.1002/cyto.a.22012
  • Zaynagetdinov, (2013), Am J Respir Cell Mol Biol., 49, pp. 180, 10.1165/rcmb.2012-0366MA
  • del Rio, (2010), J Leukoc Biol., 87, pp. 223, 10.1189/jlb.0809590
  • Rodriguez-Barbosa, (2017), Cell Mol Immunol., 14, pp. 497, 10.1038/cmi.2015.101
  • Rodriguez-Garcia, (2011), J Leukoc Biol., 89, pp. 507, 10.1189/jlb.0610327
  • Planes, (2014), J Virol., 88, pp. 6672, 10.1128/JVI.00825-14
  • Benedict, (2008), J Immunol., 180, pp. 4836, 10.4049/jimmunol.180.7.4836
  • McNally, (2013), J Virol., 87, pp. 12916, 10.1128/JVI.02423-13
  • Jin, (2013), J Virol., 87, pp. 11538, 10.1128/JVI.01967-13
  • Heinecke, (2008), J Allergy Clin Immunol., 121, pp. 1155, 10.1016/j.jaci.2008.02.009
  • Watanabe, (2003), Nat Immunol., 4, pp. 670, 10.1038/ni944
  • Inoue, (2015), Anticancer Res., 35, pp. 1361
  • Derre, (2010), J Clin Invest., 120, pp. 157, 10.1172/JCI40070
  • Murphy, (2006), Nat Rev Immunol., 6, pp. 671, 10.1038/nri1917
  • Ramsay, (2012), Blood., 120, pp. 1412, 10.1182/blood-2012-02-411678
  • Vigano, (2014), PLoS Pathog., 10, pp. e1004380, 10.1371/journal.ppat.1004380
  • Pombo, (2015), J Infect Dis., 212, pp. 1376, 10.1093/infdis/jiv226
  • Blackburn, (2010), J Virol., 84, pp. 2078, 10.1128/JVI.01579-09
  • Zhang, (2020), Front Immunol., 11, pp. 2188, 10.3389/fimmu.2020.02188
  • Lan, (2017), Onco Targets Ther., 10, pp. 919, 10.2147/OTT.S128825
  • Serriari, (2010), J Immunol., 185, pp. 3140, 10.4049/jimmunol.0902487
  • Wang, (2017), Cell Immunol., 311, pp. 36, 10.1016/j.cellimm.2016.10.002
  • Cheung, (2005), Proc Natl Acad Sci USA., 102, pp. 13218, 10.1073/pnas.0506172102